Active substances

Daunorubicin + cytarabine›

L01XY01 Antineoplastic and immunomodulating agents | Other antineoplastic agents | Combinations of antineoplastic agents

Indicated for: cancer

Decitabine›

L01BC08 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues

Indicated for: hematologic malignancies

Deferasirox›

V03AC03 Various | All other therapeutic products | All other therapeutic products | Iron chelating agents

Indicated for: iron overload

Deferiprone›

V03AC02 Various | All other therapeutic products | All other therapeutic products | Iron chelating agents

Indicated for: iron overload

Deferoxamine›

V03AC01 Various | All other therapeutic products | All other therapeutic products | Iron chelating agents

Indicated for: iron overload

Defibrotide›

B01AX01 Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Other antithrombotic agents

Indicated for: hepatic veno-occlusive disease

Degarelix›

L02BX02 Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Other hormone antagonists and related agents

Indicated for: prostate cancer

Dehydrocholic acid›

A05AAN1 Alimentary tract and metabolism | Bile therapy | Bile acids and derivatives

Indicated for: hepatobiliary disorders

Delamanide›

J04AK06 Antiinfectives for systemic use | Drugs for treatment of tuberculosis | Other drugs for treatment of tuberculosis

Indicated for: tuberculosis

Demeclocycline + triamcinolone›

A01ACN1 Alimentary tract and metabolism | Stomatological preparations | Stomatological preparations | Corticosteroids for local oral treatment

Indicated for: inflammatory dermatoses

Denosumab›

M05BX04 Musculo-skeletal system | Drugs affecting bone structure and mineralization | Other drugs affecting bone structure and mineralization

Indicated for: osteoporosis; bone metastases; tumor-induced hypercalcemia

Deoxycholic acid›

D11AX24 Dermatologicals | Other dermatological preparations | Other dermatological preparations | Other dermatologicals

Indicated for: submental fat reduction

Deproteinized hemoderivative from calf blood›

A16AXN1 Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Various alimentary tract and metabolism products

Indicated for: healing of skin lesions

Dequalinium›

G01AC05 Genito urinary system and sex hormones | Antiinfectives and antiseptics, excl. combinations with corticosteroids | Quinoline derivatives

Indicated for: local antisepsis

Desartan cilexetil + hydrochlorothiazide›

C09CA06 Cardiovascular system | Angiotensin II receptor blockers (arbs), plain | Angiotensin ii receptor blockers (arbs), plain

Indicated for: hypertension

Desflurane›

N01AB07 Nervous system | Anesthetics | Anesthetics, general | Halogenated hydrocarbons

Indicated for: general anesthesia; procedural sedation

Desirudine›

B01AE01 Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Direct thrombin inhibitors

Indicated for: prevention and treatment of thromboembolism

Desloratadine›

R06AX27 Respiratory system | Antihistamines for systemic use | Antihistamines for systemic use | Other antihistamines for systemic use

Indicated for: allergic rhinitis; urticaria

Desloratadine + pseudoephedrine›

R01BA52 Respiratory system | Nasal decongestants for systemic use | Sympathomimetics

Indicated for: nasal congestion; rhinitis

Desmopressin›

H01BA02 Systemic hormonal preparations, excluding sex hormones and insulins | Posterior pituitary lobe hormones | Vasopressin and analogues

Indicated for: diabetes insipidus; nocturnal enuresis

Desogestrel›

G03AC09 Genito urinary system and sex hormones | Hormonal contraceptives for systemic use | Progestogens

Indicated for: contraception

Desogestrel + ethinylestradiol›

G03AB05 Genito urinary system and sex hormones | Hormonal contraceptives for systemic use | Progestogens and estrogens, sequential preparations

Indicated for: contraception

Desogestrel + ethylestradiol›

G03AA09 Genito urinary system and sex hormones | Hormonal contraceptives for systemic use | Progestogens and estrogens, fixed combinations

Indicated for: contraception

Desonide›

S01BA11 Sensory organs | Antiinflammatory agents | Corticosteroids, plain

Indicated for: inflammatory dermatoses

Deucravacitinib›

L04AF07 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Janus-associated kinase (JAK) inhibitors

Indicated for: autoimmune inflammatory diseases

Dexamethasone›

H02AB02 Systemic hormonal preparations, excluding sex hormones and insulins | Corticosteroids for systemic use | Corticosteroids for systemic use, plain | Glucocorticoids

Indicated for: inflammation; cancer; COVID-19

Dexamethasone + framycetin›

S01CA01 Sensory organs | Antiinflammatory agents and antiinfectives in combination | Corticosteroids and antiinfectives in combination

Indicated for: ocular or ear inflammation with bacterial component

Dexamethasone + levofloxacin›

S01CA01 Sensory organs | Antiinflammatory agents and antiinfectives in combination | Corticosteroids and antiinfectives in combination

Indicated for: bacterial infections

Dexamethasone + neomycin›

S01CA05 Sensory organs | Antiinflammatory agents and antiinfectives in combination | Corticosteroids and antiinfectives in combination

Indicated for: bacterial infections

Dexibuprofen›

M01AE14 Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Propionic acid derivatives

Indicated for: pain and inflammation